Evidence map›Paper›PMID 37181565›Full record

ArticleFrontiers in neurology2023

Effects of esketamine on postoperative rebound pain in patients undergoing unilateral total knee arthroplasty: a single-center, randomized, double-blind, placebo-controlled trial protocol.

Youzhuang Zhu, Qun Li, Guilin Liu, Fang Sheng, Xiaotian Zhang, Lili Jiang, Shaona Li, Jianshuai He, Zhijin Zou, Baobo Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Youzhuang ZhuDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qun LiDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guilin LiuDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Fang ShengDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xiaotian ZhangDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Lili JiangDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Shaona LiDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Jianshuai HeDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhijin ZouDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Baobo ZhangDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Changyao WangDepartment of Joint Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Xin JiangPhase I Clinical Trial Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yang ZhaoDepartment of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Qingdao University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rebound pain, transient and acute postoperative pain after the disappearance of regional block anesthesia, has been a concern in recent years. Insufficient preemptive analgesia and hyperalgesia induced by regional block are the main mechanisms. At present, the evidence for the treatment of rebound pain is limited. The esketamine, as an antagonist of the N-methyl-D-aspartate receptor, has been proven to prevent hyperalgesia. Therefore, this trial aims to evaluate the impact of esketamine on postoperative rebound pain in patients undergoing total knee arthroplasty. Methods/design: This study is a single-center, prospective, double-blind, randomized, placebo-controlled trial. Participants who plan to undergo total knee arthroplasty will be randomly assigned to the esketamine group ( Discussion: The effect of ketamine on preventing postoperative rebound pain is contradictory and uncertain. The affinity of esketamine to the N-methyl-D-aspartate receptor is about four times higher than levo-ketamine, the analgesic effect is 3 times higher than levo-ketamine, and there are fewer adverse mental reactions. To our knowledge, there is no randomized controlled trial to verify the impact of esketamine on postoperative rebound pain in patients undergoing total knee arthroplasty. Therefore, this trial is expected to fill an important gap in relevant fields and provide novel evidence for individualized pain management. Clinical Trial Registration: http://www.chictr.org.cn, identifier ChiCTR2300069044.

Indexed as

esketaminehyperalgesiapostoperative acute painrebound paintotal knee arthroplasty

Identifiers

PMID37181565
PMCPMC10174246
OpenAlexW4367185072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.